These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16495931)

  • 1. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
    Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
    Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS-1: A cellular disintegrin and metalloprotease with thrombospondin motifs is a target for parathyroid hormone in bone.
    Miles RR; Sluka JP; Halladay DL; Santerre RF; Hale LV; Bloem L; Thirunavukkarasu K; Galvin RJ; Hock JM; Onyia JE
    Endocrinology; 2000 Dec; 141(12):4533-42. PubMed ID: 11108265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
    Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
    J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
    Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
    Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of microsomal prostaglandin e synthase-1 overexpression in human non-small-cell lung cancer.
    Wang HW; Hsueh CT; Lin CF; Chou TY; Hsu WH; Wang LS; Wu YC
    Ann Surg Oncol; 2006 Sep; 13(9):1224-34. PubMed ID: 16952028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
    Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
    Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis.
    Ohtsuka T; Shiomi T; Shimoda M; Kodama T; Amour A; Murphy G; Ohuchi E; Kobayashi K; Okada Y
    Int J Cancer; 2006 Jan; 118(2):263-73. PubMed ID: 16052521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of ADAMTS1 in non-small cell lung cancer.
    Choi JE; Kim DS; Kim EJ; Chae MH; Cha SI; Kim CH; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2008 Dec; 187(2):80-4. PubMed ID: 19027488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.
    Mino N; Miyahara R; Nakayama E; Takahashi T; Takahashi A; Iwakiri S; Sonobe M; Okubo K; Hirata T; Sehara A; Date H
    J Surg Oncol; 2009 Sep; 100(3):267-72. PubMed ID: 19544357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
    J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.
    Al-Fakhri N; Wilhelm J; Hahn M; Heidt M; Hehrlein FW; Endisch AM; Hupp T; Cherian SM; Bobryshev YV; Lord RS; Katz N
    J Cell Biochem; 2003 Jul; 89(4):808-23. PubMed ID: 12858346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
    Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
    Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
    Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
    J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung.
    Hashimoto H; Ozeki Y; Sato M; Obara K; Matsutani N; Nakagishi Y; Ogata T; Maehara T
    Cancer; 2006 Apr; 106(7):1595-601. PubMed ID: 16489621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
    Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
    Hida Y; Hamada J
    Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.